1
Christopher Feistel: Systems and methods for performing magnetic chromatography assays. Wavesense, Stetina Brunda Garred & Brucker, March 30, 2004: US06713271 (9 worldwide citation)

Novel magnetic assay methods and systems. According to a preferred embodiment, a chromatographic medium, which preferably comprises a test strip, is provided that is designed to be contacted with a test solution having activated magnetic particles such that the solution flows bilaterally thereacross ...


2
Feistel Christopher: Methods for performing magnetic chromatography assays. Wavesense, July 31, 2002: EP1226434-A1

Novel magnetic assay methods and systems. According to a preferred embodiment, a chromatographic medium, which preferably comprises a test strip, is provided that is designed to be contacted with a test solution having activated magnetic particles such that the solution flows bilaterally thereacross ...


3
Feistel Christopher: Systemes et methodes dexecution de dosages par chromatographie magnetique, Systems and methods for performing magnetic chromatography assays. Wavesense, Wavesense, Gowling Lafleur Henderson, June 14, 2011: CA2387788

Novel magnetic assay methods and systems. According to a preferred embodiment, a chromatographic medium, which preferably comprises a test strip, is provided that is designed to be contacted with a test solution having activated magnetic particles such that the solution flows bilaterally thereacross ...


4
Feistel Christopher: Systems and methods for performing magnetic chromatography assays. Wavesense, STETINA Kit M, April 26, 2001: WO/2001/029559

Novel magnetic assay methods and systems. According to a preferred embodiment, a chromatographic medium, which preferably comprises a test strip, is provided that is designed to be contacted with a test solution having activated magnetic particles such that the solution flows bilaterally thereacross ...


5
PROSTATIC LIQUID BIOPSY FOR THE DETECTION OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA. WAVESENSE, September 14, 2017: US20170261510-A1

Disclosed are methods to induce dislodgement of target prostatic cells from the prostate organ, collecting said cells, and subsequently examining the cell population. Such methods comprise the administration of an agent that facilitates the dislodgement of the target cells from within the prostate, ...